Residual curarization and postoperative respiratory complications following laparoscopic sleeve gastrectomy. The effect of reversal agents: sugammadex vs. neostigmine

1. Hines R, Barash PG, Watrous G, O’Connor T. Complications occurring in the postanesthesia care unit: a survey. Anesth Analg 1992;74:503-9.10.1213/00000539-199204000-000061554116Search in Google Scholar

2. Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010;112:1013-22.10.1097/ALN.0b013e3181cded0720234315Search in Google Scholar

3. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the Postanesthesia Care Unit. Anesth Analg 2008;107:130-7.10.1213/ane.0b013e31816d126818635478Search in Google Scholar

4. Rose DK, Cohen MM, Wigglesworth DF, DeBoer DP, Math M.Critical respiratory events in the postanesthesia care unit:patient, surgical, and anesthetic factors. Anesthesiology 1994;81:410-18.10.1097/00000542-199408000-000208053592Search in Google Scholar

5. Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Vender JS, Gray J, Landry E, Gupta DK. Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology. 2011;115:946-54.10.1097/ALN.0b013e318234284021946094Search in Google Scholar

6. Sauer M, Stahn A, Soltesz S, Noeldge-Schomburg G, Mencke T. The influence of residual neuromuscular block on theincidence of critical respiratory events. A randomised,prospective, placebo-controlled trial. Eur J Anaesthesiol 2011;28:842-48.10.1097/EJA.0b013e328345cd1121455074Search in Google Scholar

7. Suzuki T, Masaki G, Ogawa S. Neostigmine-induced reversal of vecuronium in normal weight, overweight and obese female patients. Br. J. Anaesth 2006;97: 160-3.10.1093/bja/ael14216782976Search in Google Scholar

8. Gaszynski T, Szewczyk T, Gaszynski W. Randomized comparison of sugammadex and neostigmine for reversal of rocuroniuminduced muscle relaxation in morbidly obese undergoing general anaesthesia. Br J Anaesth. 2012;108:236-9.10.1093/bja/aer33022012861Search in Google Scholar

9. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC:Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001;56:213-8.Search in Google Scholar

10. McDonagh DL, Benedict PE, Kovac AL, Drover DR, Brister NW, Morte JB, Monk TG. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients. Anesthesiology. 2011;114:318-29.10.1097/ALN.0b013e3182065c3621239968Search in Google Scholar

11. Magnusson L, Spahn DR. New concepts of atelectasis during general anaesthesia. Br J Anaesth 2003;9:61-72. Anesth Analg. 2004;99:1086-9.Search in Google Scholar

12. Arbous MS, Meursing AEE, van Kleef JW, de Lange JJ, Spoormans HH, Touw P, Werner FM, Grobbee DE. Impact of anesthesia management characteristics on severemorbidity and mortality. Anesthesiology 2005;102:257- 68.10.1097/00000542-200502000-0000515681938Search in Google Scholar

13. Leykin Y, Pellis T, Lucca M, Lomangino G, Marzano B, Gullo A. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients.Anesth Analg 2004;99:1086-9.10.1213/01.ANE.0000120081.99080.C215385355Search in Google Scholar

14. Suy K, Morias K, Cammu G et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007;106:283-88.10.1097/00000542-200702000-0001617264722Search in Google Scholar

15. Van Lancker P, Dillemans B, Bogaert T, Mulier JP, De Kock M, Haspeslagh M. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients. Anaesthesia 2011;66:721-25. 10.1111/j.1365-2044.2011.06782.x21692760Search in Google Scholar